Related Experiment Video
Updated: Jul 17, 2026
09:30
Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies
Published on: March 17, 2023
Pharma-Planta: road testing the developing regulatory guidelines for plant-made pharmaceuticals.
Penelope Amelia Claire Sparrow1, Judith A Irwin, Phil J Dale
1John Innes Centre, Norwich Research Park, Norwich, NR4 7UH, UK. penelope.sparrow@bbsrc.ac.uk
Transgenic Research
|February 8, 2007
Summary
Plant-made pharmaceuticals (PMPs) are nearing commercialization, prompting regulatory review in Europe. This involves developing risk assessments for health and environmental impacts to ensure oversight.
Area of Science:
- Biotechnology
- Pharmaceutical Sciences
- Regulatory Science
Background:
- Plant-made pharmaceuticals (PMPs) have advanced to clinical trials, with commercial products anticipated soon.
- Europe is preparing for PMP commercialization, with products entering Phase II clinical trials.
- Emerging PMPs will challenge existing regulations for genetically modified (GM) plants and conventional pharmaceuticals.
Purpose of the Study:
- To discuss the regulatory landscape for PMPs in Europe.
- To address the development of risk-assessment and risk-management strategies for PMPs.
- To ensure appropriate regulatory oversight by EU authorities.
Main Methods:
- Review of current regulatory frameworks for GM plants and pharmaceuticals.
- Analysis of health and environmental impact assessment methodologies.
- Engagement with EU regulatory agencies on PMP guidelines.
Main Results:
- PMP technology is progressing towards market entry, necessitating regulatory adaptation.
- EU regulatory responsibilities for PMPs are being defined.
- Specific guidelines for PMP regulation are under development.
Conclusions:
- Robust risk assessment and management are crucial for PMP development.
- Collaboration with EU regulatory authorities is essential for appropriate oversight.
- The commercialization of PMPs in Europe requires a clear and effective regulatory pathway.
Related Concept Videos
01:28Preclinical Development: Overview
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
01:25Drug Regulation
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
01:11Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
01:29Clinically Relevant Drug Product Specifications: Methods of Establishment
Product specifications define the acceptable quality of a pharmaceutical product by ensuring identity, purity, potency, and strength. These specifications serve as benchmarks during development, manufacturing, and post-approval quality control. Clinically relevant specifications are particularly important because they directly relate to a drug's safety and efficacy in clinical use.Dissolution studies are critical biopharmaceutic tools that link in vitro behavior to in vivo performance. They...
01:10In Vitro Drug Release Testing: Overview, Development and Validation
In vitro dissolution and drug release tests assess how quickly and how much of a drug is released from its dosage form into an aqueous medium under standardized laboratory conditions. These tests are essential tools in pharmaceutical development and quality assurance, offering insight into the drug's performance before clinical use.During formulation development, dissolution testing identifies incomplete or inconsistent drug release issues. It also supports decisions on selecting the optimal...
01:30Production of Pharmaceuticals
Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under sterile, tightly...